FEMININE TIME Trademark
Trademark Overview
On Thursday, April 29, 1982, a trademark application was filed for FEMININE TIME with the United States Patent and Trademark Office. The USPTO has given the FEMININE TIME trademark a serial number of 73362187. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, December 15, 1983. This trademark is owned by LIFELONG PRODUCTS U.S.A.. The FEMININE TIME trademark is filed in the Pharmaceutical Products category with the following description:
HERBAL SUPPLEMENTS IN TABLET FORM
General Information
| Serial Number | 73362187 |
| Word Mark | FEMININE TIME |
| Filing Date | Thursday, April 29, 1982 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, December 15, 1983 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | HERBAL SUPPLEMENTS IN TABLET FORM |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 018 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | Sunday, March 21, 1982 |
| First Use In Commerce Date | Sunday, March 21, 1982 |
Trademark Owner History
| Party Name | LIFELONG PRODUCTS U.S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | IRVINE, CA 92714 |
Trademark Events
| Event Date | Event Description |
| Thursday, December 15, 1983 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, March 11, 1983 | ASSIGNED TO EXAMINER |
